In a move to help position the company to keep pace with a growing demand for the development of biologics, which currently represent nearly 50% of AstraZeneca’s (IW 1000/170) overall pipeline, the company announced plans to expand its biologics manufacturing center in Frederick, Md.
The more than $200 million project will increase production capacity. Biologics currently represents nearly 50% of AstraZeneca’s overall pipeline....More
The new manufacturing plant will take four years to build and will create 350-400 highly skilled jobs, including scientists, engineers and bio-process operators, and up to 1,000 temporary construction jobs....More
The building has been built making use of tens of 3M’s own inventions and innovations, such as the lighting technology, air and water filers, decorative films as well as 3M’s Very High Bonding (VHB) gluing technology used to glue together all glass panels in the building....More